# The Long-term Effect of Marine Omega-3 Fatty Acid Supplementation in Renal Transplantation

> **NCT03018041** · PHASE3 · COMPLETED · sponsor: **Joe Chan** · enrollment: 174 (actual)

## Conditions studied

- Kidney Transplantation

## Interventions

- **DRUG:** Omacor
- **DRUG:** Placebo Oral Capsule

## Key facts

- **NCT ID:** NCT03018041
- **Lead sponsor:** Joe Chan
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-01
- **Primary completion:** 2024-03-22
- **Final completion:** 2025-03-22
- **Target enrollment:** 174 (ACTUAL)
- **Last updated:** 2025-04-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03018041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03018041, "The Long-term Effect of Marine Omega-3 Fatty Acid Supplementation in Renal Transplantation". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03018041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*